Medovate Forms Partnership with Konica Minolta Healthcare Americas to Promote Best Practice in Regional Anesthesia

OrthoNext Digital Platform for the JuniOrtho Plating System Receives FDA Clearance

“Together, OrthoNext and the JuniOrtho Plating System provide a complete solution for surgeons looking for a plating system to address the specific demands of advanced deformity and trauma reconstruction of the lower extremities in the pediatric population,” said Orthofix President of Global Orthopedics Paul Gonsalves.

SonarMed, New Pediatric Monitor Alerts Clinicians To Potential Airway Obstructions During Ventilation Launched

"The SonarMed airway monitoring device has revolutionized the way we care for our littlest patients. There is no other device in the world that can tell you where the endotracheal tube is located within the airway continuously in real-time, and whether the tube is obstructed or even partially occluded," said Jamie W. Powers, M.D., MBA, neonatologist at Huntington Hospital in Pasadena, California.

January 28, 2021

Medovate notes the partnership will highlight the provision of Ultrasound-Guided Regional Anesthesia and how the revolutionary SAFIRA™ (SAFer Injection for Regional Anesthesia) can be used in conjunction with Konica Minolta Healthcare Americas’ Inc. range of pioneering ultrasound solutions.

SAFIRA™ is a Class II medical device set to transform regional anesthesia around the world by making it a one-person procedure. It puts control of the injection in the hands of the anesthesiologist freeing up their assistants to carry out other tasks. The device also helps to improve patient safety by reducing the risk of nerve damage as it prevents injection above 20psi.

The introduction of ultrasound guidance in regional anesthesia was first explored by anesthesiologists in the mid-1990s and since then technology advancements have led to an increase in ultrasound by anesthesiologists.

Ultrasound guidance offers a range of important practical advantages for nerve blockade such as visualization of the anatomy and more informed guidance for the needle pathway avoiding structures that might be damaged by the needle. It also reduces the likelihood of inadvertent needle trauma to unintended structures and ensures the continued visualization of the local anesthetic solution.

Together the two technologies present a best practice solution in delivering regional anesthesia.

Speaking about the partnership, Chris Rogers, Sales and Marketing Director at Medovate, said: “We are excited to be partnering with Konica Minolta Healthcare Americas, a world leader in ultrasound technology. The company has a strong focus on creating value through innovation – an ethos that fits with Medovate’s core focus on realizing the benefits of clinician-led innovation. We are looking forward to raising awareness of ultrasound-guided techniques for regional anesthesia.”

Recent publications, including a joint statement by the American Society of Regional Anesthesia and Pain Management (ASRA) and the European Society of Regional Anaesthesia and Pain Therapy (ESRA), have recommended regional anesthesia be considered whenever surgery is planned for a suspected or confirmed COVID-19 patient. This is because it preserves respiratory function and avoids aerosolization and the potential for transmission of COVID-19 compared to general anesthesia.

“Medovate brings a unique combination of clinical innovation and expertise through its association with the United Kingdom’s National Health Service and we are proud to partner with them to advance regional anesthesia,” says Eric Sumner, Executive Vice President Ultrasound Sales at Konica Minolta. “Our companies have a shared vision to promote safer solutions that deliver clinical efficiency, simplify use and advance better outcomes for patients.”

Joan Toth, Senior Product Marketing Manager for Konica Minolta Healthcare Americas Inc. adds, “Our companies are committed to furthering the use of regional anesthesia in the US. Through Konica Minolta’s UGPro solution, we’ll provide the latest ultrasound technology and procedural innovations, such as SAFIRA, along with hands-on education to help anesthesiologists offer this important alternative to their patients. Medovate’s clinical knowledge and experience are invaluable and we are excited to partner with them.”




Subscribe to Medical Device News Magazine here.

Related Articles